Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 15

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part II, Item 4
Chunk 15
---
DepreciationNumberof IssuesFairValueAmortizedCostUnrealizedDepreciationNumberof IssuesOne year or lessInvestment grade$276 $278 $(2)121$1,203 $1,227 $(24)545 Below investment grade52 58 (6)252245 250 (5)739 More than one yearInvestment grade3,389 3,747 (358)9184,687 5,319 (632)1,297 Below investment grade213 231 (18)74416 469 (53)123 Total$3,930 $4,314 $(384)1,365 $6,551 $7,265 $(714)2,704 

20

Equity SecuritiesThe following table provides the values of the Company's equity security investments: September 30, 2025 December 31, 2024(In millions) CostCarrying Value CostCarrying ValueEquity securities with readily determinable fair values$641 $134 $635 $37 Equity securities with no readily determinable fair value6,167 3,383 3,215 524 Total$6,808 $3,517 $3,850 $561 In the third quarter of 2025, the Company invested $3.5 billion in preferred stock of Shields and a compounding dividend is recorded in Fees and other revenues within the Consolidated Statements of Income. The investment is included in equity securities with no readily determinable fair value in the table above.

Commercial Mortgage Loans

Mortgage loans held by the Company are made exclusively to commercial borrowers and are diversified by property type, location and borrower. Loans are generally issued at fixed rates of interest and are secured by high-quality, primarily completed and substantially leased operating properties.

The Company regularly evaluates and monitors credit risk from the initial mortgage loan underwriting and throughout the investment holding period. The annual portfolio review performed in the second quarter of 2025 confirmed ongoing strong overall credit quality in line with the previous year's results. For more information on the Company's accounting policies and methodologies regarding these investments, see Note 11 in the Company's 2024 Form 10-K.

The following table summarizes the credit risk profile of the Company's commercial mortgage loan portfolio:(Dollars in millions)September 30, 2025December 31, 2024Loan-to-Value RatioCarrying